Nobody in the MedTech regulatory world likes to talk about specific numbers. Consultants say "it depends." Notified Bodies say "request a quote." Conference speakers give ranges so wide they are useless. And startup founders are left trying to build financial models with guesswork.
This post breaks that pattern. We are going to give you real cost ranges — not from a textbook, but from what Tibor has seen across 50+ certifications working with startups and established companies alike. These numbers reflect 2026 market conditions in Europe.
A caveat before we begin: every device is different. A Class IIa software application has different cost drivers than a Class IIb implantable sensor. The numbers below are ranges, not quotes. Use them for planning, not for purchasing.
The Cost Categories
CE marking costs fall into six major categories:
- Quality Management System (QMS) setup and maintenance
- Technical documentation preparation
- Testing and verification
- Clinical evaluation and clinical evidence
- Notified Body fees
- Regulatory expertise (internal or external)
Let us walk through each one.
1. Quality Management System Setup
Range: EUR 15,000 - 80,000 (initial setup)
Every manufacturer needs a QMS aligned with ISO 13485:2016 and meeting the requirements of MDR Article 10(9).
The lean approach (EUR 15,000 - 30,000): Using an electronic QMS (eQMS) platform designed for startups, adapting template SOPs, and having a regulatory professional review and customize them for your specific device and processes. Monthly eQMS platform costs range from EUR 200-800/month depending on the platform and number of users.
The mid-range approach (EUR 30,000 - 50,000): Custom-built QMS with regulatory consulting support, more extensive SOP development, training for the team, and internal audit preparation.
The comprehensive approach (EUR 50,000 - 80,000): Full QMS build with extensive consulting support, mock audits, process validation, and thorough implementation across all relevant departments. More typical for Class IIb/III devices where the QMS complexity is higher.
Ongoing annual cost: EUR 10,000 - 30,000/year QMS maintenance includes internal audits, management reviews, document updates, CAPA management, and continuous improvement. This is not optional — a QMS that is not maintained is a QMS that will fail its next audit.
Tibor's take: "Startups always underestimate QMS costs because they think of it as a one-time project. It is not. It is a permanent operating cost of being a medical device manufacturer. Budget for it annually, not just at setup."
2. Technical Documentation Preparation
Range: EUR 20,000 - 150,000+
The technical file is the most variable cost because it depends entirely on your device's complexity.
Class I device (simple, non-active): EUR 20,000 - 40,000 Basic device description, GSPR checklist, risk management file, verification reports, labeling content. Relatively straightforward but still requires rigor.
Class IIa device (moderate complexity): EUR 40,000 - 80,000 More extensive documentation, more testing, more detailed risk management, clinical evaluation, software lifecycle documentation (if applicable). This is the range where most SaMD startups land.
Class IIb device: EUR 60,000 - 120,000 Comprehensive documentation with detailed design verification and validation, extensive risk analysis, thorough biocompatibility assessment (if applicable), and more rigorous clinical evaluation.
Class III device: EUR 100,000 - 150,000+ Maximum documentation depth. Detailed design history, comprehensive verification and validation testing, extensive clinical evidence, benefit-risk analysis at the highest level of rigor.
These numbers assume some internal regulatory capability. If you outsource 100% of technical documentation writing to an external regulatory consultant, add 30-50% to these ranges.
3. Testing and Verification
Range: EUR 10,000 - 200,000+
Testing costs are among the most variable because they depend on what your device is and what standards apply.
Software-only devices (SaMD): - Software verification and validation: EUR 10,000 - 40,000 (internal effort, plus any external testing tools) - IEC 62304 software lifecycle documentation: included in technical documentation costs above - Cybersecurity testing (if applicable): EUR 5,000 - 20,000 - Usability engineering and testing (IEC 62366-1): EUR 10,000 - 30,000 - Total software testing: EUR 25,000 - 90,000
Active electrical devices: - Electrical safety testing (IEC 60601-1 + collateral standards): EUR 15,000 - 50,000 - EMC testing (IEC 60601-1-2): EUR 10,000 - 30,000 - Software testing (if applicable): EUR 10,000 - 40,000 - Usability testing: EUR 10,000 - 30,000 - Biocompatibility (if applicable, ISO 10993): EUR 15,000 - 60,000 - Environmental testing: EUR 5,000 - 15,000 - Total active device testing: EUR 50,000 - 200,000+
Non-active devices: - Biocompatibility (ISO 10993): EUR 15,000 - 60,000 - Performance testing: EUR 10,000 - 50,000 - Shelf life / stability testing: EUR 5,000 - 20,000 - Sterility validation (if sterile): EUR 20,000 - 60,000 - Packaging validation: EUR 5,000 - 15,000 - Total non-active device testing: EUR 30,000 - 150,000
Tibor's advice on testing: "Get quotes from test laboratories early. Really early. Laboratory costs and lead times are two of the biggest surprises for startups. A single biocompatibility test program can cost EUR 40,000 and take four months. Know this before you build your budget and timeline."
4. Clinical Evaluation and Clinical Evidence
Range: EUR 10,000 - 500,000+
This is the widest range and the cost category that can make or break a startup's budget.
Literature-based clinical evaluation (no clinical investigation): - Systematic literature search: EUR 3,000 - 8,000 - Clinical evaluation report (CER) writing: EUR 10,000 - 30,000 - Expert review: EUR 2,000 - 5,000 - Total: EUR 15,000 - 43,000
This route works for lower-risk devices where sufficient clinical data exists in published literature, or where equivalence to an existing device can be demonstrated.
Clinical evaluation with equivalence claim: - Everything above, plus equivalence demonstration: EUR 5,000 - 15,000 additional - Access to equivalent device data (if contractual access needed): variable, potentially EUR 0 if you have a legitimate relationship with the manufacturer - Total: EUR 20,000 - 60,000
Clinical investigation (clinical trial): - Study design and protocol writing: EUR 15,000 - 40,000 - Ethics committee submissions: EUR 2,000 - 10,000 - Competent authority notification: EUR 1,000 - 5,000 - Site costs (investigator fees, per-patient costs): EUR 50,000 - 300,000+ (highly variable based on study size, duration, and complexity) - Monitoring and data management: EUR 20,000 - 80,000 - Statistical analysis: EUR 5,000 - 20,000 - Clinical study report: EUR 10,000 - 30,000 - CER update with investigation results: EUR 10,000 - 20,000 - Total: EUR 100,000 - 500,000+
For Class III and implantable devices, a clinical investigation is often unavoidable under MDR's tightened equivalence requirements per Article 61. This is frequently the single largest cost in the entire CE marking process.
5. Notified Body Fees
Range: EUR 0 (Class I self-certification) to EUR 50,000 - 150,000+ (Class III)
Notified Body fees vary by organization, device complexity, and scope of work. Here are representative ranges:
Class I (no NB involvement): EUR 0 You self-certify. No Notified Body fees.
Class I sterile / measuring / reprocessing: EUR 8,000 - 20,000 Limited scope involvement.
Class IIa: EUR 20,000 - 50,000 Includes application review, QMS audit, technical documentation assessment, and certificate issuance.
Class IIb: EUR 35,000 - 80,000 More extensive review scope.
Class III: EUR 50,000 - 150,000+ Most extensive review, including detailed clinical evidence assessment and potential expert panel consultation fees.
Annual surveillance fees: EUR 10,000 - 40,000/year After initial certification, the Notified Body conducts annual surveillance audits (at least one of which may be unannounced). These are billed separately and are an ongoing cost for the life of the certificate.
Important note: these are the Notified Body's fees for their work. They do not include your internal costs of preparing for and supporting the Notified Body assessment.
6. Regulatory Expertise
Range: EUR 0 (fully internal) to EUR 100,000+ (fully outsourced)
Unless you have experienced regulatory professionals on your team, you will need external support. The options range from:
Fractional regulatory lead (part-time engagement): EUR 2,000 - 8,000/month A senior regulatory professional who works with your team on a part-time basis, guiding strategy, reviewing documentation, and mentoring your internal team. This is often the most cost-effective option for startups.
Full-service regulatory consulting: EUR 150 - 350/hour Project-based engagement for specific deliverables (classification, clinical evaluation strategy, GSPR checklist, etc.). Costs accumulate quickly — 200 hours of consulting at EUR 250/hour is EUR 50,000.
In-house regulatory hire: EUR 60,000 - 100,000/year (salary + benefits, DACH market) For startups at the stage where regulatory is a full-time need. The most expensive option in cash flow terms but the most efficient long-term if you have a portfolio of devices.
Tibor's honest perspective on external help: "I tell every startup the same thing. You need at least one person on your team who understands regulatory. It does not have to be a 20-year veteran. It can be someone who has done one certification and learned from it. But you need someone internal who owns the regulatory strategy. External consultants — including me — are sparring partners, not replacement regulatory departments."
Total Cost Summary by Device Class
Here are the total cost ranges, combining all six categories:
Class I (self-certification): - Low end: EUR 50,000 - Mid range: EUR 80,000 - 120,000 - High end: EUR 150,000
Class IIa: - Low end: EUR 120,000 - Mid range: EUR 200,000 - 350,000 - High end: EUR 500,000
Class IIb: - Low end: EUR 250,000 - Mid range: EUR 400,000 - 600,000 - High end: EUR 800,000+
Class III: - Low end: EUR 400,000 - Mid range: EUR 600,000 - 1,000,000 - High end: EUR 1,500,000+
These are first-certification costs. They include QMS setup, technical documentation, testing, clinical evaluation, Notified Body fees, and external regulatory support. They do not include the ongoing annual costs of maintaining certification (QMS maintenance, surveillance audits, post-market surveillance, clinical evaluation updates).
The Costs Nobody Tells You About
Beyond the six major categories, several costs catch startups by surprise:
Translations. If your device is sold in multiple EU Member States, your Instructions for Use must be in the official language(s) of each Member State. Professional medical device translation is specialized and expensive — EUR 50-150 per page depending on language pair and complexity.
EUDAMED registration fees. Currently, EUDAMED itself does not charge registration fees, but the administrative effort of preparing and maintaining your EUDAMED entries has an internal cost.
UDI implementation. Implementing Unique Device Identification (UDI) requires obtaining UDI codes from an issuing entity, updating labeling, and integrating UDI into your systems. Issuing entity fees and labeling changes add EUR 2,000 - 10,000 depending on the number of device variants.
Design changes after submission. If you need to modify your device during the Notified Body review — because of a clinical finding, a testing failure, or a market insight — the cost of updating documentation, re-running tests, and re-submitting to the Notified Body can be substantial. Plan your design freeze carefully.
Recalls and field safety corrective actions. Not a certification cost per se, but something to budget for. If a post-market issue requires a recall or field safety corrective action, the costs can be significant. Having reserves for this is part of responsible medical device manufacturing.
How to Minimize Costs Without Cutting Corners
Cost optimization in regulatory is not about spending less — it is about spending wisely:
1. Get the classification right the first time. A wrong classification wastes months and tens of thousands of euros when you discover the error mid-process.
2. Invest in documentation quality upfront. Every Notified Body revision cycle costs money — your internal time plus the Notified Body's additional review fees. A well-prepared first submission is the best cost-saving measure.
3. Use harmonized standards. They provide a clear, accepted path to demonstrating conformity. Deviating from harmonized standards is possible but requires more work to justify — and more work means more cost.
4. Plan your testing program strategically. Combine tests where possible. Sequence tests logically so that a failure early in the program does not waste downstream testing budget.
5. Use electronic QMS platforms. They are dramatically cheaper than building a paper-based or custom-software QMS. The startup-focused eQMS market in 2026 offers good options at reasonable monthly costs.
6. Consider the fractional regulatory model. A part-time senior regulatory professional is often more cost-effective than either a full-time hire (too expensive for early-stage) or hourly consulting (unpredictable costs).
The Investment Perspective
Here is the reframe that every founder needs: CE marking is not a cost. It is an investment in market access.
The EU medical device market is worth approximately EUR 150 billion. Without a CE mark, you have zero access to it. The EUR 200,000-500,000 you spend on certification for a Class IIa device is the price of entry to a market that can sustain your company for decades.
Compare it to other startup investments: a seed round of EUR 1-2 million, of which EUR 200-400K goes to regulatory, is a reasonable allocation for a MedTech company. It is not wasted — it produces a tangible, valuable asset (the CE mark and the underlying quality system) that has direct commercial value.
Tibor frames it this way: "Every euro you spend on regulatory competence is an investment in your company's ability to operate in the most lucrative medical device market in the world. And unlike marketing spend, the regulatory investment compounds — your QMS, your technical documentation, your clinical evidence, your Notified Body relationship — all of these carry forward into your next product, your next market, your next round of funding."
The Bottom Line
CE marking under MDR is not cheap. For most startups, it represents one of their largest expenditure categories. But it is also completely predictable if you plan properly. The cost surprises come from not understanding the full scope, not from the process itself being unpredictable.
Know your device class. Understand the conformity assessment route. Map the cost categories. Build a budget with realistic ranges. Add a contingency buffer of 20-30%. And start the regulatory workstream early enough that you are not paying premium rates for expedited timelines because you started too late.
The companies that treat regulatory budgeting as a serious financial planning exercise — rather than a line item they will "figure out later" — are the ones that get to market on budget and on time.